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DNA-dependent protein kinase (DNA-PK), which is involved in DNA double-strand break repair and V(D)J
recombination, is comprised of a DNA-targeting component termed Ku and an ∼465-kD catalytic subunit,
DNA-PKcs. Although DNA-PK phosphorylates proteins in the presence of DSBs or other discontinuities in the
DNA double helix in vitro, the possibility exists that it is also activated in other circumstances via its
association with additional proteins. Here, through use of the yeast two-hybrid screen, we discover that the
recently identified high affinity DNA binding protein C1D interacts with the putative leucine zipper region of
DNA-PKcs. Furthermore, we show that C1D can interact with DNA-PK in mammalian cells and that C1D is a
very effective DNA-PK substrate in vitro. Finally, we establish that C1D directs the activation of DNA-PK in
a manner that does not require DNA termini. Therefore, these studies provide a function for C1D and suggest
novel mechanisms for DNA-PK activation in vivo.
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The DNA double-strand break (DSB) is one of the most
dangerous and potentially lethal lesions that can occur
within the cell. DNA DSBs can arise when DNA repli-
cation complexes encounter damage or secondary struc-
tures in the DNA template, by free radical damage as a
consequence of oxidative metabolism, or are induced by
ionizing radiation (IR) or radiomimetic chemicals. DNA
DSBs are also generated as intermediate structures dur-
ing V(D)J recombination, which mediates the rearrange-
ment of immunoglobulin and T-cell receptor genes (for
review, see Alt et al. 1992; Gellert 1992). Therefore, DSB
repair is not only critical for maintaining genomic integ-
rity but is also essential for the normal development of
the immune system.
Genetic and biochemical complementation studies
have revealed that DSB repair and V(D)J recombination
are reliant on the DNA-dependent protein kinase (DNA-
PK). DNA-PK is an abundant nuclear protein serine/
threonine kinase that is activated in vitro by DNA DSBs
and certain other perturbations in the DNA double helix
(for review, see Anderson and Lees-Miller 1992; Jackson
1997; Smith et al. 1998). Biochemical studies have re-
vealed that DNA-PK is a multiprotein complex consist-
ing of a ∼465-kD catalytic subunit termed DNA-PKcs and
a DNA-binding component called Ku, which is com-
posed of two tightly associated polypeptides of ∼70 and
∼80 kD (Ku70 and Ku80, respectively; Dvir et al. 1993;
Gottlieb and Jackson 1993). DNA-PK has been shown to
phosphorylate a variety of proteins in vitro, including
Hsp90, Sp1, SV40 T antigen, p53, serum response factor
(SRF), c-Fos, c-Jun, and the carboxy-terminal domain of
RNA polymerase II (Anderson and Lees-Miller 1992;
Jackson 1997). Although Ku helps to recruit DNA-PKcs
to DNA in vitro and is thus likely to be required for the
physiological activation of DNA-PK at sites of DNA
damage, there is evidence that, at least in vitro, DNA-
PKcs can bind to DNA and exhibit kinase activity in the
absence of Ku (Yaneva et al. 1997; Hammarsten and Chu
1998). The activation of DNA-PK by DNA DSBs suggests
that it may function in vivo by recognizing recombina-
tion intermediates and/or DNA ends at sites of DNA
damage. Defects in DNA-PK components cause radio-
sensitivity and an inability to perform V(D)J recombina-
tion (for review, see Jackson and Jeggo 1995; Jackson
1996; Lieber et al. 1997).
The biochemical characteristics of DNA-PK have led
to several hypotheses regarding its function in vivo (Jack-
son and Jeggo 1995; Roth et al. 1995 and references
therein). For example, it has been suggested that DNA-
PK may align the broken DNA ends or interact directly
with other components of the DNA repair machinery to
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target them to sites of DNA damage. Alternatively, or in
addition, DNA-PK might function by modifying the ac-
tivity of DNA repair factors by phosphorylation. It could
also counteract the action of transcription factors or
chromatin, which might otherwise interfere with the as-
sembly of the DNA repair complex. Finally, and consis-
tent with the fact that DNA-PKcs is related to several
factors involved in DNA damage-induced cell cycle
checkpoint control processes (Hartley et al. 1995; Keith
and Schreiber 1995; Jackson 1997), DNA-PK activation
could trigger DNA damage signaling cascades that ulti-
mately impinge on the transcription, DNA replication,
cell cycle, and/or apoptotic machineries.
Despite the substantial progress achieved in recent
years in our understanding of DNA-PK, a number of is-
sues concerning its physiological functions and mecha-
nism of action remain outstanding. For example, al-
though several proteins have been found to act as DNA-
PK substrates in vitro, factors phosphorylated by DNA-
PK in vivo have yet to be defined unequivocally. Clearly,
the identification of physiological targets for DNA-PK
would greatly facilitate investigations into the mecha-
nisms and consequences of DNA-PK activation. In addi-
tion, it remains to be established whether there are situ-
ations in vivo in which DNA-PK activation does not
involve free DNA ends and, if so, whether this is brought
about by DNA-PK associating with additional proteins.
Regarding this point, it should be noted that DNA-PK is
present at ∼1 × 105 to 5 × 105 molecules per human cell,
which is far in excess of the number of DNA DSBs gen-
erated by physiological doses of DNA damaging agents.
Although one explanation for this is that large quantities
of DNA-PK are required to allow the rapid detection and
repair of DNA damage, an alternative model is that
DNA-PK may have functions in addition to its roles in
DNA DSB repair. A final crucial issue is that all assays
for DNA-PK have so far employed naked DNA tem-
plates, whereas it is clear that DNA is complexed with
histones and various nonhistone proteins in vivo. The
question thus arises as to whether such chromatin com-
ponents exert positive or negative influences on DNA-
PK activation. Notably, in this regard the chromatin-
associated high mobility group (HMG) proteins 1 and 2
have been shown to stimulate DNA-PK activity in vitro
(Watanabe et al. 1994) and recent investigations have
established that certain proteins required for heterochro-
matin-mediated gene silencing in yeast interact with Ku
and are required for effective DNA DSB repair (Tsuka-
moto et al. 1997; Boulton and Jackson 1998).
As an approach to address some of the above issues, we
have applied the yeast two-hybrid system (Fields and
Song 1989) to screen for polypeptides that interact with
DNA-PKcs. As reported herein, such an approach has led
us to identify a novel protein, C1D, which interacts spe-
cifically with the potential leucine zipper (LZ) region of
DNA-PKcs both in vitro and in vivo. We also show that
C1D is a very efficient substrate for DNA-PK in vitro.
Moreover, unlike most other DNA-PK substrates iden-
tified so far, which are phosphorylated by DNA-PK only
in the presence of linear DNA, C1D can activate DNA-
PK in the presence of a supercoiled plasmid DNA mol-
ecule. The potential implications of these results in re-
gard to the biological roles of C1D and DNA-PK in DNA
repair, V(D)J recombination, and other processes are dis-
cussed.
Results
Identification of proteins interacting with the putative
LZ region of DNA-PKcs
The cloning of the cDNA for human DNA-PKcs has re-
vealed that it encodes a protein of ∼465 kD that pos-
sesses a phosphatidylinositol 3-kinase (PIK) catalytic do-
main toward its carboxyl terminus (Hartley et al. 1995).
Other than this, the only other significant feature that
has been noted previously for the DNA-PKcs polypeptide
is the presence of a potential LZ motif encompassing
residues 1503–1538 (Fig. 1A). Because some LZs have
well-documented roles in mediating protein–protein in-
teractions, we decided to see whether we could identify
factors that interact with this region of DNA-PKcs by the
yeast two-hybrid screen approach. To this end, we gen-
erated the yeast expression plasmid pLexA–LZcs, which
directs the synthesis of residues 1501–1602 of DNA-PKcs
fused to the carboxy-terminal DNA-binding domain of
the bacterial LexA protein (this fusion is referred to as
pLexA–LZcs). pLexA–LZcs was then introduced into the
yeast reporter strain L40 (Hollenberg et al. 1995) that
contains both the HIS3 and lacZ genes under the control
of LexA operators. Importantly, L40 containing pLexA–
LZcs is His
− and expresses no detectable b-galactosidase
activity, indicating that the LZ region of DNA-PKcs is
transcriptionally inert when fused to LexA.
Strain L40 containing pLexA–LZcs was transformed
with a human B-lymphocyte cDNA library in the vector
pACT. A total of ∼1 × 106 transformants were obtained,
of which, ∼1 × 103 were capable of growing on medium
lacking histidine. Of these, 300 were found to produce
elevated b-galactosidase activity. After elimination of
false positives by use of other LexA fusion proteins
(linked to the proteins Lamin and Daughterless) as baits,
100 transformants were identified as containing cDNAs
that conferred a His+, LacZ+ phenotype in a fashion that
was specific to L40 cells expressing the LexA–DNA-PKcs
fusion protein. The cDNA expression vectors from 20 of
these transformants were then rescued, and sequencing
revealed that 17 contained overlapping sequences de-
rived from the same cDNA. A search of the GenBank
database revealed that this cDNA corresponds to that of
a 16-kD polypeptide, termed C1D (GenBank accession
no. X95592). C1D is a ubiquitously expressed nuclear
protein that has been identified recently by screening a
cDNA expression library with monoclonal antibodies
raised against the residual polypeptides that remain at-
tached to DNA even following aggressive purification
methods that employ SDS, proteinase K, and phenol ex-
traction (Nehls et al. 1998; U. Yavuzer and S.P. Jackson,
unpubl.; also see Discussion). Notably, the amino acid
sequence of C1D does not reveal significant homologies
DNA-PK activation without DNA ends
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with any known functional protein domains nor to pre-
viously characterized proteins.
C1D interacts with the putative LZ region
of DNA-PKcs specifically
To establish the specificity of the two-hybrid interaction
between C1D and the LZ region of DNA-PKcs, the res-
cued C1D cDNA clone was transformed into L40 to-
gether with baits comprising the LexA DNA-binding do-
main alone, LexA–LZcs, LexA–Daughterless, or LexA–
Lamin, and the level of activity from the integrated lacZ
reporter was determined in each case. As shown in Fig-
ure 1B, C1D interacts with LexA–LZcs very strongly but
not with LexA alone, LexA–Daughterless, nor LexA–La-
min. To confirm the specificity of the C1D–DNA-PKcs
interaction further, we performed the two-hybrid experi-
ment in reverse. Thus, C1D was fused to the carboxy-
terminal DNA-binding region of LexA, and the region of
DNA-PKcs containing the LZ was fused to the VP16 ac-
tivation domain. Significantly, the introduction of plas-
mids expressing these two proteins into strain L40 re-
sults in significant b-galactosidase activity (Fig. 1C),
whereas only background b-galactosidase activity is de-
tected when LexA alone is tested for a two-hybrid inter-
action with VP16–LZcs. Therefore, C1D and the region
encompassing the putative LZ motif of DNA-PKcs can
interact irrespective of which acts as bait.
Because the region of DNA-PKcs used in the above
studies comprises ∼100 amino acid residues and extends
beyond the putative LZ motif, we wished to determine
whether this motif is required for the interaction with
C1D. To this end, two specific mutations were intro-
duced into the LZ motif, and the ability of each of these
mutated derivatives to interact with C1D in the two-
hybrid assay was compared with that of the wild-type
polypeptide. In one mutant, termed mut1LZcs, the sec-
ond leucine residue within the LZ motif is mutated to a
proline residue, whereas in the second mutant,
mut2LZcs, the third leucine and preceding glutamic acid
residue are mutated to proline and aspartic acid residues,
respectively (Fig. 1A). Notably, as shown in Figure 1D,
although C1D interacts efficiently with the wild-type
DNA-PKcs derivative, no significant interaction is de-
tected for each of the specific point mutations affecting
the integrity of the LZ motif. These data therefore reveal
that the two-hybrid interaction between DNA-PKcs and
C1D requires an intact DNA-PKcs LZ motif and suggest
strongly that this region mediates, at least in part, the
interaction between these two factors.
C1D and DNA-PKcs interact in vitro
Next, we wanted to determine whether C1D is able to
bind to DNA-PKcs in vitro. To this end, C1D was ex-
pressed in Escherichia coli as a fusion to GST, was pu-
rified by use of glutathione–agarose beads, and the im-
mobilized GST–C1D fusion protein was then incubated
with a protein fraction containing the DNA-PK holoen-
zyme. After extensive washing of the beads, the proteins
bound to GST–C1D were resolved by SDS-PAGE fol-
lowed by Western blotting and probing with an antibody
specific for DNA-PKcs. As shown in Figure 2A, although
no interaction is observed between DNA-PKcs and GST
alone, a substantial proportion (∼10%) of the input DNA-
PKcs is bound by GST–C1D. In contrast, when a control
Figure 1. C1D interacts with the LZ region of
DNA-PKcs. (A) Schematic diagram of DNA-
PKcs. The kinase domain (hatched box) and the
LZ region used as a bait in the yeast two-hybrid
system are indicated. Mutations introduced
into the LZ motif to produce constructs,
Mut1LZcs and Mut2LZcs, are indicated by aster-
isks, and the leucine residues of the motif are
underlined. (B) C1D fused to VP16 activation
domain (Prey) was transformed into L40 strain
together with LexA–LZcs, LexA, or other LexA
fusion proteins (Lamin and Daughterless). Inter-
actions were measured by b-galactosidase activ-
ity. (C) C1D fused to the carboxy-terminal
DNA-binding region of LexA (Bait), and the
LZcs was fused to the VP16 activation domain.
(D) Mutations that disrupt the LZ motif abolish
the DNA-PKcs—C1D two-hybrid interaction.
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protein was employed consisting of a fusion of GST to
the protein CBP, no interaction with DNA-PKcs was ap-
parent (data not shown). Because the DNA-PKcs prepa-
ration used for the above assays also contained Ku, we
were prompted to ascertain whether C1D binds DNA-
PKcs alone or whether it can interact with the Ku–DNA-
PKcs complex. In addition, because both C1D and Ku can
bind to DNA, it was important to see whether the inter-
action detected was direct or was mediated indirectly via
DNA that might have contaminated either the GST–
C1D or DNA-PK samples. To address these issues, we
used ethidium bromide, which disrupts protein–DNA
interactions by intercalating into the DNA double helix
(Lai and Herr 1992). Thus, GST–C1D was tested for in-
teractions with DNA-PKcs and Ku in the presence or
absence of ethidium bromide. Significantly, these stud-
ies revealed that whereas both DNA-PKcs and Ku bind to
the GST–C1D beads in the absence of ethidium bromide,
in the presence of ethidium bromide, only DNA-PKcs is
retained (Fig. 2B). Taken together, these data indicate
that the C1D–DNA-PKcs interaction is direct and does
not appear to be mediated by or require a DNA cofactor.
In contrast, C1D does not interact with Ku directly, al-
though these factors can associate indirectly in the pres-
ence of DNA, presumably via their interactions with
DNA-PKcs. Consistent with this, no interaction is ob-
served between C1D and Ku in the absence of ethidium
bromide in reactions that lack DNA-PKcs (data not
shown). Finally, these results suggest strongly that
DNA-PKcs is able to contact both C1D and Ku simulta-
neously.
C1D is an efficient substrate for DNA-PK in vitro
The interaction between DNA-PKcs and C1D suggested
that C1D might represent a substrate for DNA-PK and/
or might regulate DNA-PK activity. To address these
issues, we expressed full-length C1D in E. coli as a His-
tagged fusion protein. Notably, this protein on its own is
highly insoluble under nondenaturing conditions, but
can be obtained in soluble form by denaturing it with 8
M urea and then gradually refolding the protein by with-
drawing the urea by dialysis in the presence of either
linear or supercoiled plasmid DNA. Such a procedure
results in soluble DNA-bound C1D (if DNA is not pre-
sent in the dialysis procedure, essentially all C1D be-
comes insoluble; D. Werner and U. Yavuzer, unpubl.).
Recombinant C1D purified and refolded by this method
was recognized by rabbit polyclonal sera raised against
either the His-tagged C1D or a GST–C1D fusion protein
(see Materials and Methods). To determine whether C1D
can serve as a substrate for DNA-PK, we incubated the
His-tagged C1D that had been assembled onto a linear
plasmid molecule with DNA-PK (comprising DNA-PKcs
and Ku) in the presence of [g32P]-ATP. These studies re-
vealed that C1D is recognized very effectively as a DNA-
PK substrate, with phosphorylation being of similar ef-
ficiency to the well-characterized DNA-PK substrate p53
(Fig. 3A, lanes 3,4). However, the GST–C1D fusion pro-
tein was not recognized as a substrate, presumably be-
cause of the target site(s) on C1D being obscured.
C1D activates DNA-PK in the presence of supercoiled
plasmid DNA
Previous studies have established that DNA-PK inter-
acts with DNA ends and, therefore, is activated strongly
by linear DNA but only weakly, if at all, by closed–cir-
cular plasmid DNA (Gottlieb and Jackson 1993; Suwa et
al. 1994). In the course of our investigations into C1D
phosphorylation by DNA-PK, we made the surprising
observation that C1D assembled onto a supercoiled plas-
mid DNA (pKTMLP) also serves as a very effective DNA-
PK substrate (Fig. 3B, lane 4). Furthermore, the inclusion
of free supercoiled plasmid DNA does not result in an
increase in C1D phosphorylation (Fig. 3B, lane 3). The
phosphorylation of C1D is dependent on the presence of
the DNA-PK preparation, because no C1D phosphoryla-
tion is obtained either with C1D alone or with C1D to-
gether with free plasmid DNA (Fig. 3B, lanes 1 and 7,
respectively).
Although the above studies utilized highly purified
DNA-PK, the possibility existed that C1D might be be-
Figure 2. C1D and DNA-PKcs interact in vitro. (A) GST or
GST–C1D (0.5 µg in each case) was incubated with 5 µg of
purified DNA-PK and subjected to GST pull-down assays, and
Western blots were performed with a DNA-PKcs antibody.
Quantitation reveals that ∼10% of DNA-PKcs binds to GST–
C1D in this experiment, suggestive of a 1:1 binding ratio. (B)
GST pull-downs were performed as in A (for lane 3, the pull-
down reaction included ethidium bromide), then proteins were
immunoblotted with antibodies against Ku or DNA-PKcs.
DNA-PK activation without DNA ends
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ing phosphorylated not by DNA-PK but by a contami-
nating kinase in the DNA-PK preparation. To address
this issue, we took advantage of the fact that the fungal
metabolite wortmannin and the synthetic agent
LY294002 have been shown to be potent inhibitors of
DNA-PK but do not affect most characterized protein
Ser/Thr kinases (G. Smith, N. Lakin, and S.P. Jackson,
unpubl.). Significantly, the phosphorylation of C1D by
DNA-PK preparations is abolished by the addition of ei-
ther wortmannin (data not shown) or LY294002 (Fig. 3B,
lane 5). In addition, phosphorylation is abrogated in the
presence of ethidium bromide (Fig. 3B, lane 6). These
data therefore provide strong support that the active
C1D kinase is DNA-PK. Given that C1D interacts di-
rectly with DNA-PKcs but not Ku, we asked whether
C1D could be phosphorylated by DNA-PKcs in the ab-
sence of Ku. As seen in Figure 3C, no phosphorylation of
C1D is observed in the presence of DNA-PKcs or Ku
alone, and phosphorylation is detected only when both
proteins are present concurrently. Taken together, these
data reveal that although C1D phosphorylation by DNA-
PK is DNA dependent, it differs from other well-charac-
terized DNA-PK-mediated phosphorylation events in
that it can be promoted by supercoiled plasmid DNA
(also, see below). Nevertheless, Ku is still required for
DNA-PKcs to phosphorylate C1D that is bound to a su-
percoiled plasmid molecule.
C1D that is associated with supercoiled DNA can
direct the phosphorylation of other polypeptides
by DNA-PK
The above results reveal that C1D interacts with DNA-
PKcs and show that DNA-PK can phosphorylate C1D
which is bound to supercoiled plasmid DNA. To see
whether C1D can induce DNA-PK to phosphorylate
other substrates in the presence of supercoiled DNA and
whether it can substitute for Ku in these events, we ana-
lyzed the effect of C1D that was bound to supercoiled
DNA (C1D-Sc) on the ability of DNA-PK to phosphory-
late a synthetic peptide derived from the amino-terminal
transcriptional activation region of p53 (Anderson and
Lees-Miller 1992; Finnie et al. 1995). As a control, a mu-
tant peptide was used that is not phosphorylated by
DNA-PK. Consistent with previous observations, addi-
tion of linear DNA to reactions containing both DNA-
PKcs and Ku was found to result in strong kinase activity
(Fig. 4A, lane 4), whereas the p53-derived peptide is phos-
phorylated poorly in reactions containing DNA-PKcs
alone or containing DNA-PKcs in the presence of super-
coiled DNA (Fig. 4A, lanes 1 and 2, respectively). More-
over, addition of purified Ku, the DNA-end-binding pro-
tein poly(ADP)–ribose polymerase (PARP), or bovine se-
rum albumin (BSA) does not increase DNA-PK-mediated
kinase activity in the presence of supercoiled DNA (Fig.
4, lanes 8–10, respectively). However, the inclusion of
C1D-Sc in reactions containing DNA-PKcs results in a
slight but significant increase in kinase activity com-
pared with that obtained with DNA-PKcs alone, suggest-
ing that C1D is able to activate DNA-PKcs for phos-
phorylation of other protein targets (Fig. 4A, cf. lanes 1
and 5). Most strikingly, addition of Ku to such reactions
results in kinase activity as strong as that obtained with
linear DNA (Fig. 4A, lanes 6,4).
Because C1D used in the above experiments had been
refolded onto supercoiled plasmid DNA and because no
additional DNA was used, we considered it a possibility
that the DNA present in the C1D preparation had be-
come degraded, and it was this degraded DNA that led to
DNA-PK activation. To determine whether this was the
case, the DNA present in the refolded C1D preparation
was purified by sequential phenol and chloroform extrac-
tions. Analysis of such DNA by agarose gel electropho-
resis revealed that it was still almost entirely supercoiled
(data not shown). Moreover, when this recovered DNA is
added to reactions containing Ku and DNA-PKcs, no sig-
nificant stimulation of DNA-PK-mediated p53 peptide
kinase activity is observed (Fig. 4A, lane 7). Therefore,
Figure 3. C1D is a strong substrate for DNA-PK in vitro. (A)
C1D refolded on a linear plasmid (C1D-L) or p53 was incubated
with purified DNA-PK, and in vitro kinase assays were per-
formed as described in Materials and Methods. Linear DNA was
added to the reaction for lane 4. (B) C1D refolded on supercoiled
plasmid (C1D-Sc) was incubated with purified DNA-PK as de-
scribed above. Where indicated, ethidium bromide or LY294002
were incubated with proteins for 30 min before starting the
kinase reaction. (C) As indicated, highly purified DNA-PKcs
and/or Ku was incubated with C1D-Sc and kinase assays were
performed.
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the supercoiled DNA to which C1D was bound had not
become degraded. To address the possibility that a nucle-
ase might exist in C1D preparations and become active
only under kinase assays conditions, we incubated C1D-
Sc and DNA-PK together under kinase assay conditions
(containing Mg2+) with a radiolabeled DNA fragment.
No degradation of the DNA was detectable when it was
subsequently analyzed alongside its untreated control by
electrophoresis on a denaturing urea/polyacrylamide gel
(data not shown). As a final control, we assembled a ki-
nase reaction containing C1D-Sc, DNA-PKcs/Ku, incu-
bated this under kinase assay conditions, and then ex-
tracted the DNA. As shown in Fig. 4C, this DNA (Rxn
DNA) was unable to promote DNA-PK activation, re-
vealing that it had not become degraded. Taken together,
these results show that the C1D preparation used is de-
void of detectable nuclease activity and reveal that
DNA-PK activation ensues only when supercoiled plas-
mid DNA is complexed to C1D. In addition, they reveal
that Ku is required for DNA-PKcs to be stimulated maxi-
mally by C1D-Sc. To confirm these conclusions, reac-
tions containing DNA-PKcs and Ku together with C1D-
Sc were preincubated for 30 min with either preimmune
serum, anti-C1D antiserum, or anti-Ku antiserum, be-
fore being tested for phosphorylation of the p53-derived
peptide (Fig. 4B). These studies revealed that whereas
incubation with preimmune serum does not affect DNA-
PK mediated kinase activity significantly, kinase activ-
ity is essentially abolished on incubation with either
anti-C1D antiserum or with anti-Ku antiserum (the anti-
C1D antiserum used here was raised against a different
recombinant version of C1D than that used in the kinase
assay; see legend to Fig. 4B for details). These results,
therefore, reinforce the notion that both C1D and Ku are
required for the efficient activation of DNA-PKcs by su-
percoiled DNA.
Because the above studies utilized a synthetic peptide
derived from p53, and because p53 has been implicated
recently as an in vivo target for DNA-PK (Shieh et al.
1997), we tested whether similar effects are obtained
with the full-length p53 protein. Importantly, virtually
no protein phosphorylation is observed in assays with
either DNA-PK (DNA-PKcs plus Ku), p53, or C1D-Sc
alone (Fig. 5A, lanes 1–3). Furthermore, and consistent
with previous work, p53 phosphorylation by DNA-PK is
very poor in the absence of added DNA (Fig. 5A, lane 5),
and is stimulated strongly by the addition of linear DNA
(lane 6) but not by supercoiled DNA (lane 7). Hence, in
the absence of C1D, efficient phosphorylation of p53 by
DNA-PK is dependent on the DNA in the assay being
linear. In contrast, when supercoiled DNA is used that
has been assembled with C1D, p53 is phosphorylated as
efficiently as it is in the presence of linear DNA (Fig. 5A,
lane 8; C1D is also phosphorylated under these condi-
tions). Because addition of increasing amounts of super-
coiled plasmid DNA or purified supercoiled DNA de-
rived from the refolded C1D preparation (see above) does
not cause any increase in p53 phosphorylation (data not
shown), we conclude that the ability of DNA-PK to phos-
phorylate p53 in the presence of supercoiled DNA is de-
pendent on C1D. In line with this and with results ob-
tained with the peptide phosphorylation studies, the
phosphorylation of the p53 protein is inhibited by prein-
cubation with anti-C1D or anti-Ku serum but not with
preimmune serum (Fig. 5B).
DNA-PK and C1D can interact in mammalian cells
In light of the above data, we wished to test whether
DNA-PKcs and C1D are capable of interacting with one
another in mammalian cells. Furthermore, because the
interaction between DNA-PK and the protein c-Abl has
been shown to be stimulated in response to DNA dam-
Figure 4. C1D activates DNA-PK when bound to a supercoiled
plasmid. (A) DNA-PK activity was tested by standard DNA-PK
peptide assays (see Materials and Methods) in the presence of
the indicated components. In reactions 8 and 9, PARP or BSA
were used instead of C1D-Sc. A total of 800 ng of C1D-Sc was
subjected to sequential phenol/chloroform extraction (f/
CHCl3) and the DNA was precipitated, resuspended in a small
amount of water, and added into reaction 7 (this amount of
DNA is in excess of the amount in 100 ng of C1D-Sc; lanes
5,6,10). Where indicated, 100 ng of excess supercoiled (Sc) or
linear (L) DNA was added. (B) Proteins were incubated with the
indicated antibodies for 30 min on ice and the kinase reaction
was started by adding [g32P]ATP. The anti-C1D antiserum used
in this experiment was raised against the GST–C1D fusion and,
therefore, is a distinct derivative from the recombinant His-
tagged version of C1D used in the kinase assay. (C) DNA-PK
peptide phosphorylation assays were conducted with the indi-
cated components. To generate the Rxn DNA, a standard kinase
assay was conducted containing C1D-Sc, DNA-PKcs, and Ku,
then the DNA was retrieved by f/CHCl3 extraction and pre-
cipitation.
DNA-PK activation without DNA ends
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age (Kharbanda et al. 1997), we wanted to determine
whether this is also the case for the interaction between
C1D and DNA-PKcs. Although initial experiments were
designed to address an interaction between endogenous
mammalian cell C1D and DNA-PKcs in coimmunopre-
cipitation assays, such studies were not feasible because
C1D remains tightly bound to DNA during whole cell or
nuclear extract preparation and, consequently, is not de-
tectable by Western blotting of soluble cell extracts
(Nehls et al. 1998; U. Yavuzer, unpubl.). To circumvent
this problem, we expressed recombinant C1D in mam-
malian cells in anticipation that a fraction of the ex-
pressed protein would remain soluble following cell ex-
tract preparation. Thus, COS cells were transiently
transfected with a vector expressing an HA epitope-
tagged version of human C1D. After 48 hr, lysates were
prepared from the transfected cells with or without prior
exposure to 15 Gy of IR, and were immunoprecipitated
with anti-DNA-PKcs, anti-HA, or preimmune sera. The
immunoprecipitates were then analyzed by Western
blotting with an anti-HA antibody or an anti-DNA-PKcs
antiserum. As shown in Figure 6A, a protein of ∼22 kD is
detected by the anti-HA antibody in anti-DNA-PKcs im-
munoprecipitates derived from transfected cells (Fig. 6A,
lanes 2,4). In contrast, no such protein is evident when
extracts of transfected cells are immunoprecipitated
with preimmune serum (Fig. 6A, lanes 1,3), nor when
extracts of untransfected cells are immunoprecipitated
with the anti-DNA-PKcs antiserum (lane 6). When the
blot was stripped and reprobed with an anti-C1D antise-
rum, the protein of ∼22 kD was again detected in anti-
DNA-PKcs immunoprecipitates derived from transfected
cells (data not shown). In light of these results, and be-
cause the predicted molecular mass of HA-tagged C1D is
∼22 kD, these data suggest strongly that the protein im-
munoprecipitated by the anti-DNA-PKcs antisera from
extracts of transfected cells is C1D.
To further verify the interaction between DNA-PKcs
and C1D detected above, we conducted the immunopre-
cipitation experiments in reverse by analyzing immuno-
precipitates of C1D for the presence of DNA-PKcs. No-
tably, DNA-PKcs is recovered in anti-HA immuno-
precipitates of cells transfected with the HA–C1D ex-
pression construct (Fig. 6B, lane 2) but is not evident in
preimmune immunoprecipitates of transfected cell ex-
tracts or in anti-HA immunoprecipitates from extracts of
untransfected cells (Fig. 6B, lanes 1 and 4, respectively).
Taken together, these data indicate that C1D interacts
with DNA-PKcs in unfractionated mammalian cell ex-
Figure 6. C1D and DNA-PKcs interact in mammalian cells. (A)
Lysates from untransfected (lane 6) or HA–C1D-transfected
COS cells (lanes 1–5) were immunoprecipitated with preim-
mune (PI), anti-DNA-PKcs, or anti-HA antisera. For lanes 3 and
4, the cells were treated with 15 Gy of ionizing irradiation be-
fore lysate preparation. Western blotting was performed by an
anti-HA antibody. The higher band is the IgG light chain (25
kD). (B) Lysates from transfected and untransfected cells were
immunoprecipitated with the antisera described in A, and the
Western blot was developed by anti-DNA-PKcs antibody.
Figure 5. C1D can activate DNA-PK to phosphorylate full-
length p53, and this activation is C1D-dependent. (A) DNA-PK,
C1D-Sc, and p53 were incubated as described in Materials and
Methods. Where indicated, 100 ng of linear (L) or supercoiled
(Sc) plasmid was included. (B) Assays were conducted as in A,
except that proteins were incubated with the indicated antibod-
ies before reactions were initiated by the addition of [g-32P]ATP.
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tracts. Significantly, however, and in contrast to the situ-
ation reported for the interaction between DNA-PKcs
and c-Abl, no significant change in the association be-
tween C1D and DNA-PKcs is evident in response to IR
(Fig. 6A, cf. lanes 2 and 4).
C1D is induced in response to IR
Although DNA damage has been shown to activate the
kinase activity of DNA-PK in vitro, the molecular
mechanisms underlying activation of DNA-PK in vivo
have yet to be established. One possibility is that the
interaction between C1D and DNA-PKcs plays some role
in the regulation of DNA-PK activity in vivo in response
to DNA damage. No difference in the association be-
tween DNA-PK and C1D in response to DNA damage
was detected in the transfection assays described above.
However, because C1D expression in these experiments
was under the control of a heterologous promoter, any
potential effects of IR on C1D expression may have been
overlooked. Therefore, we analyzed C1D levels in total
cell lysates by Western immunoblot analysis either be-
fore or after exposing cells to 15 Gy of IR. As shown in
Figure 7A (left), following IR treatment there is robust
induction in the levels of a protein of ∼18 kD (the pre-
dicted size of endogenous C1D) that is recognized by an
antiserum raised against recombinant His-tagged C1D.
In contrast, no significant induction of this protein was
observed in response to UV irradiation. To confirm that
the protein induced by IR is C1D, the blot was stripped
and reprobed with another C1D antibody raised against a
GST–C1D fusion protein (a-C1D 2). As seen in Figure 7A
(right), the same ∼18 kD protein band is recognized by
this second antibody, providing strong evidence that it is
C1D. To determine whether the induction of C1D is at
the mRNA level, RNA prepared from irradiated and non-
irradiated cells was analyzed by quantitative RT PCR. As
shown in Figure 7B, C1D mRNA levels are barely detect-
able in nonirradiated cells but are induced ∼10-fold on
exposing cells to IR. Significantly, no difference is ob-
served in the level of GAPDH expression between irra-
diated and nonirradiated cells. Thus, both C1D protein
and mRNA are increased in response to g-irradiation.
Discussion
Previous work on DNA-PK has revealed that its catalytic
activity in vitro is stimulated markedly by the presence
of free DNA ends. Although DNA-PKcs itself has been
shown recently to have an inherent capability to bind to
and be activated by DNA DSBs (Yaneva et al. 1997; Ham-
marsten and Chu 1998), efficient activation of the en-
zyme in vitro requires the DNA end-binding protein Ku.
In line with DNA-PKcs and Ku functioning in concert in
vivo, the loss of either component leads to defects in
DNA DSB repair and V(D)J recombination in cell lines
and animal systems. These observations suggest strongly
that DNA-PK is recruited to DSBs in vivo. The results
presented in this manuscript reveal an alternative
mechanism by which DNA-PK catalytic activity may be
regulated. Specifically, we show that DNA-PK can be
activated in the absence of DSBs through association
with the recently identified ∼18-kD-cellular protein
termed C1D. This suggests that alternative mechanisms
may exist for DNA-PK activation in vivo.
Using the yeast two-hybrid approach to screen a hu-
man B-lymphocyte library, we have discovered that C1D
binds specifically to the putative LZ motif of DNA-PKcs.
Furthermore, we have demonstrated the importance for
the DNA-PKcs LZ motif by showing that point muta-
tions of key residues within it severely inhibit the two-
hybrid interaction with C1D. In addition, we have estab-
lished that full-length derivatives of DNA-PKcs and C1D
can interact in vitro and in vivo, either as purified pro-
teins or when they are present in unfractionated mam-
malian cell extracts. Significantly, the binding of DNA-
PKcs to C1D appears to be direct, as evidenced by the fact
that it does not require DNA and is not disrupted by the
addition of ethidium bromide. In contrast, no direct in-
teraction between C1D and Ku is detectable by the as-
says that we have used, although Ku does appear to as-
sociate with C1D indirectly via DNA-PKcs in the pres-
ence of DNA. The apparent ability of DNA-PKcs to
contact C1D and Ku simultaneously is consistent with
the fact that the region of DNA-PKcs that interacts with
C1D is distinct from that which has been shown re-
cently to bind Ku (Shengfang et al. 1997).
C1D was identified initially as an antigen that remains
associated with DNA even after treatment with harsh
denaturants. When expressed in bacteria, C1D is highly
Figure 7. C1D is induced in response to IR. (A) Total cell lysate
from cells with or without prior exposure to 15 Gy of IR was
resolved by SDS-PAGE and transferred onto nitrocellulose.
Western blotting was performed by antibodies raised against a
His-tagged C1D (a-C1D 1) or GST–C1D (a-C1D 2) fusion pro-
teins. (B) C1D transcript expression in nonirradiated and irradi-
ated cells. RT–PCR was performed on RNA extracted from ir-
radiated or nonirradiated cells, and cDNA amplified by primers
described in Materials and Methods. GAPDH was used as an
internal control.
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insoluble in the absence of ionic detergents such as SDS,
or chaotropic agents such as urea or guanidine hydro-
chloride. However, if C1D is solubilized in the presence
of 8 M urea and the urea is then removed slowly by di-
alysis, C1D is able to refold onto DNA that is provided.
By taking advantage of this property of C1D, we have
shown that it is a very good substrate for DNA-PK me-
diated phosphorylation. Furthermore, we have found
that DNA-PK is able to phosphorylate C1D not only
when it has been refolded onto a linear DNA molecule
but also when C1D is bound to a supercoiled plasmid.
Several lines of evidence indicate that the activation of
DNA-PK in this latter instance requires C1D. First,
when the supercoiled DNA used to refold C1D was re-
trieved by repeated phenol/chloroform extractions and
was then analyzed by agarose gel electrophoresis, it was
still found to exist almost exclusively in supercoiled
form. Second, this retrieved DNA was unable to activate
DNA-PK in phosphorylation assays containing either a
synthetic peptide or the full-length p53 protein. Thus,
the DNA that had been associated with C1D had not
sustained nicks or DSBs that could have allowed it to
activate DNA-PK directly. Third, we have not detected
any nuclease activities in our C1D preparations that are
activated on incubation under kinase assay conditions.
Finally, the stimulation of DNA-PK activity by C1D in
association with supercoiled DNA is inhibited by anti-
bodies raised against C1D but not by any of the preim-
mune antisera we have tested.
Taken together, the available data suggest a model
whereby DNA-PK can be activated in the absence of
DNA ends. In this model, the interaction between C1D
and DNA-PKcs serves as a mechanism to target DNA-
PKcs to a DNA molecule. However, this complex appears
to be inactive catalytically, because we have observed no
phosphorylation of C1D or other proteins when DNA-
bound C1D is incubated with DNA-PKcs alone. Rather,
DNA-PKcs activity is only triggered when Ku subse-
quently enters the complex. One explanation for the de-
mand for Ku despite the lack of DNA ends is that C1D
alters the conformation of DNA-PKcs so that it is able to
bind to Ku without DNA ends. Alternatively, it is pos-
sible that the binding of C1D to DNA alters the DNA
structure so that it is now able to interact with Ku, and
consequently, trigger the ability of Ku to bind and acti-
vate DNA-PKcs. In this model, the inhibition of kinase
activity mediated by antibodies that recognize C1D or
Ku could be through them, preventing the assembly of
the multiprotein complex, and the inhibition effected by
ethidium bromide could be brought about by disruption
of the Ku–DNA and/or C1D–DNA interactions. Finally,
active DNA-PK may then phosphorylate various target
proteins, including C1D itself. Although the conse-
quences of C1D phosphorylation by DNA-PK are cur-
rently unclear, it is tempting to speculate that this acti-
vates C1D for some additional function(s), or dissociates
the complex between C1D and DNA-PKcs once its func-
tion is complete.
What could be the physiological role(s) for the inter-
action between C1D and DNA-PKcs and the model for
DNA-PK activation described above? One potential clue
is provided by the fact that C1D binds to DNA in an
extremely stable fashion, as evidenced by the fact that it
remains DNA-associated even after rigorous extraction
procedures. Highly stable nonhistone proteins that are
bound to DNA tightly have been identified in various
systems, including insects, plants, and mammalian cells
(Krauth and Werner 1979; Capesius et al. 1980; Bodnar et
al. 1983; Avramova and Tsanev 1987). Although the bio-
logical functions for these proteins are still largely ob-
scure, it is noteworthy that some have been reported to
be associated with highly repetitive DNA sequences and
to be involved in targeting a subset of genomic DNA to
the nuclear matrix (Neuer and Werner 1985; Neuer-
Nitsche et al. 1988; Werner and Neuer-Nitsche 1989;
Pfutz et al. 1992). This is of particular interest in regard
to the results described herein, as the nuclear matrix is
thought to provide the structural framework for nuclear/
chromatin organization, and has been shown to associ-
ate with several nuclear metabolic processes including
DNA replication, transcription, RNA splicing, topoi-
somerase activity, nucleotide excision repair, and DNA
DSB repair (Berezney 1984; Cockerill and Garrard 1986;
Nelson et al. 1986; Verheijen et al. 1988; Jackson 1991;
Kaufman and Shaper 1991; Yasui et al. 1991, 1994; Korte
and Yasui 1993; Johnston and Bryant 1994; Koehler and
Hanawalt 1996).
By operational definitions, C1D is a nuclear matrix-
associated protein and can be detected in nuclear matrix
preparations by Western immunoblots and immunoflu-
orescence. C1D is also induced by g-irradiation. There-
fore, it is possible that C1D targets DNA-PK to the
nuclear matrix and matrix-associated DNA in response
to DNA damage. Once DNA-PK is activated, it is pos-
sible that it may then allow proteins involved directly in
DNA repair to perform their functions. Alternatively, or
in addition, C1D might target DNA-PK to the nuclear
matrix constitutively. Evidence in support of the notion
that DNA-PK function is linked to the nuclear matrix
comes from the observation that the radiosensitive cell
line xrs5, which is deficient in Ku80, exhibits irregularly
shaped nuclei, has nuclear envelope abnormalities, and
has altered nuclear matrix attachment regions with re-
spect to wild-type cells (Yasui et al. 1991, 1994; Korte
and Yasui 1993). Furthermore, this cell line has also been
shown to be defective specifically in the joining of ma-
trix attached DNA DSBs (Johnston and Bryant 1994).
This suggests that the targeting of both DNA-PK and
DNA to the nuclear matrix may play a crucial role in
DNA DSB repair processes. Studies into interactions be-
tween DNA-PK and C1D, and possibly also with other
matrix associated proteins, should help address this im-
portant issue.
Materials and methods
Cloning, mutagenesis, and DNA sequencing
pLexA–LZcs was generated by cloning into the SpeI site of
pBTM116PS, the region of the DNA-PKcs cDNA corresponding
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to nucleotide residues 4560–4860 (containing a natural 58 and a
polylinker-derived 38 XbaI sites). pBTM116PS was derived from
plasmid pBTM116 (obtained from S. Elledge, HHMI, Baylor Col-
lege of Medicine, Houston, TX) by modifying the frame of the
cloning site and the addition of polystop codons. To construct
the wild-type LZ region of DNA-PKcs as a VP16 fusion (LZcs–
VP16), nucleotide residues 4381–4860 were amplified by PCR
with a 58 NotI site and XhoI–NotI sites on 38 end, and cloned
into pVP16 (obtained from S. Hollenberg) as well as pBlueskript
SK+ (pBSK+) as a NotI fragment. Mut1LZcs–VP16 was isolated in
two steps. First, DNA-PKcs nucleotide residues 4560–4860 were
isolated by PCR with mismatch primers placing an XbaI site at
the 58 end and XhoI and NotI sites at the 38 end, then replacing
this by the XbaI–XhoI fragment of wild-type LZcs in (pBSK
+).
Second, the whole fragment containing the entire LZ region of
DNA-PKcs in which the second leucine is mutated to a proline
was cut out as a NotI fragment and cloned into pVP16.
Mut2LZcs–VP16 was isolated as a linker-scanner mutation.
Nucleotide residues 4601–4860 were isolated by PCR with
primers placing BamHI and NotI sites on the 58 and 38 ends,
respectively. Residues 4381–4601 were isolated by PCR with a
58 NotI and 38 BamHI site at each end and both fragments were
cloned into NotI site in pVP16 allowing the two fragments to
join at the BamHI site in the middle, which mutates the third
leucine to a proline and the preceding glutamic acid to aspartic
acid. For bacterial and mammalian C1D expression constructs,
the ORF of C1D was isolated by PCR with primers placing
suitable restriction sites to the 58 and 38 ends and cloning into-
expression plasmids. Bacterial expression plasmids are: pGEX
(Pharmacia), pQE30 (Qiagen expression systems). For the mam-
malian expression construct, an HA epitope (a peptide derived
from influenza hemagglutinin protein)-tagged expression vector
pCMV 582N3T (Lavender et al. 1997) was used. Sequencing of
PCR fragments, point mutations, and cDNA inserts from posi-
tive clones of the two-hybrid screen was performed with an
automatic sequencer by the dideoxy termination method. Se-
quence comparisons were conducted by GenBank database
searches.
Yeast two-hybrid screen
A human B-lymphocyte cDNA library in pACT was used
(Harper et al. 1993). The other components of the system were
provided by S. Hollenberg. Saccharomyces cerevisiae L40
(MATa trp1 leu2 his3 LYS2:lexA–HIS3 URA3::lexA–lacZ) was
grown at 30°C in YPD medium (1% yeast extract, 2% polypep-
ton, and 2% glucose), was sequentially transformed with plexA–
LZcs and human B-lymphocyte cDNA library by the lithium
acetate method. Double transformants were plated on yeast
dropout medium lacking Trp, Leu, His, Lys, and uracil and were
grown at 30°C for 3 days. Colonies were then transferred on
Whatman 40 filters to test for b-galactosidase activity [with an
X-gal (5-bromo-4-chloro-3-indolyl-b-D-galactopyranoside) colony
filter assay]. Positive clones were rescued and tested for speci-
ficity by transformation into L40 either with plexA–LZcs or con-
trol plasmids plexA–Lamin, plexA–Daughterless, or plexA
alone.
Bacterial expression and purification of C1D
Expression of GST (C1DpGEXTK2) or His-tagged C1D
(C1DpQE30) fusion proteins was induced for 4 hr by adding 2
mM IPTG (isopropyl-b-O-thiogalactopyroniside) and the fusion
proteins were isolated from bacterial lysates by affinity chro-
matography by use of glutathione–agarose beads (Sigma) or Ni–
NTA agarose (Qiagen) columns, respectively. C1DpQE30 fusion
protein was purified under denaturing conditions in the pres-
ence of 8 M Urea and dialyzed against 0.1× TE in the presence of
linear or supercoiled plasmid DNA. Antibodies against the re-
combinant proteins were raised in rabbits by standard proce-
dures (Harlow and Lane 1988).
GST–pull-down assays
Purified DNA-PKcs, Ku, or the DNA-PK holoenzyme was incu-
bated for 2 hr with fusion protein bound to glutathione-coupled
agarose beads (Hagemeier et al. 1994). Precipitates were washed
several times with NETN (20 mM Tris at pH 8.0, 100 mM NaCl,
1 mM EDTA and 0.5% NP-40) and were subjected to SDS-PAGE
and Western blotting. The GST–CBP protein (CPB1; Bannister
and Kouzarides 1995) used as a control contained amino acid
residues 461–662 of CBP.
Kinase assays
Two nanograms of purified DNA-PKcs together with 5 ng of Ku
or 60 ng of DNA-PK holoenzyme was incubated for 2 min with
100 ng of C1DpQE refolded on a linear or a supercoiled DNA in
the presence of 20 µl of Z8 buffer (25 mM HEPES–KOH at pH 7.9,
50 mM KCl, 10 mM MgCl2, 20% glycerol, 0.1% NP-40, 1 mM
DTT, and 200 µM ATP) and the reaction was started by adding
10 µCi of [g-32P]ATP (6000 Ci/mmole). Following incubation at
30°C for 20 min, phosphorylated proteins were subjected to
20% SDS-PAGE and visualized by autoradiography. When used,
antibodies, ethidium bromide (200 µg/ml), or LY294002 (2.5 µM
final concentration), were incubated on ice with the proteins for
30 min before starting kinase reactions. The amount of excess
linear DNA was 100 ng. DNA-PK peptide phosphorylation as-
says were conducted as described previously (Finnie et al. 1995).
Relative DNA-PK activity was calculated by subtracting the
cpm incorporated into mutant peptide from the cpm incorpo-
rated into wild-type peptide, then dividing this by cpm incor-
porated by mutant peptide.
Cell culture and transient transfections
COS 7 (African green monkey kidney), HeLa, or NIH-3T3 cells
were maintained in DMEM supplemented with 10% fetal calf
serum and grown at 37°C with 10% CO2 as monolayers. Trans-
fections were performed by the calcium phosphate precipitation
technique. The precipitate was left on the cells for 8–10 hr be-
fore a glycerol shock (15% glycerol for 1 min) was given. Cells
were then washed twice with PBS and fresh medium was added
and cells were harvested 48 hr after transfection.
Coimmunoprecipitations
Five micrograms of HA–C1D was transfected into 1 × 108 COS
or NIH-3T3 cells as described above. Forty-eight hours follow-
ing transfection, cells were harvested and lysed in lysis buffer
(150 mM NaCl with 0.2 % NP-40). Cells that were subjected to
15 Gy of ionizing irradiation were incubated for 1 hr at 37°C
before harvesting. Lysates were incubated with appropriate sera
for 1 hr on ice and bound to protein A– or G–Sepharose for 4 hr,
rocking gently at 4°C. Precipitates were then washed three
times with the lysis buffer (15 min each), separated by 15%
SDS-PAGE, and blotted onto nitrocellulose. Western blotting
was performed with anti-HA monoclonal antibody (12CA5,
Boehringer) or a polyclonal antiserum raised against the full-
length DNA-PKcs and immunoreactive bands were revealed by
an ECL kit (Amersham) according to the manufacturer’s in-
structions.
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RT–PCR
Total RNA from irradiated or nonirradiated cells was prepared
as described (Sambrook et al. 1989), and 1 µg of RNA was used
to reverse transcribe according to the enzyme manufacturer’s
instructions (Boehringer Mannheim). The cDNA was then am-
plified with the primers 58-ATGGCAGGTGAAGAAATT and
38-ACTTTTACTTTTTCCTTT (C1D) that generates a 420-bp
fragment of the C1D cDNA, and the primers 58-CCACAG-
TCCATGCCATCACTG and 38-CGCTGTTGAAGTCAGAG-
GAGA for a 340-bp fragment of the human GAPDH cDNA.
Each PCR cycle consisted of incubation periods of 30 sec at
95°C, 1 min at 55°C, and 1 min at 72°C. PCR products were
then analyzed on a 2% agarose gel. To ensure that the PCR
reaction was quantitative, aliquots of each PCR reaction were
analyzed every 4 cycles, between 12 and 32 cycles.
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Note added in proof
C1D is apparently identical to the protein SUN-CoR, which has
recently been identified as a putative transcriptional corepres-
sor (Zamir et al. 1997 Proc. Natl. Acad. Sci. 94: 14400–14405).
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